Secondary prevention of Alzheimer’s dementia: neuroimaging contributions

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions ; volume:10 ; number:1 ; day:30 ; month:10 ; year:2018 ; pages:1-21 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (30.10.2018), 1-21, 12.2018

Creator
ten Kate, Mara
Ingala, Silvia
Schwarz, Adam J.
Fox, Nick C.
Chételat, Gaël
van Berckel, Bart N. M.
Ewers, Michael
Foley, Christopher
Gispert, Juan D.
Hill, Derek
Irizarry, Michael C.
Lammertsma, Adriaan A.
Molinuevo, José Luis
Ritchie, Craig
Scheltens, Philip
Schmidt, Mark E.
Visser, Pieter Jelle
Waldman, Adam
Wardlaw, Joanna
Haller, Sven
Barkhof, Frederik
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-018-0438-z
URN
urn:nbn:de:101:1-2018121901190508146720
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • ten Kate, Mara
  • Ingala, Silvia
  • Schwarz, Adam J.
  • Fox, Nick C.
  • Chételat, Gaël
  • van Berckel, Bart N. M.
  • Ewers, Michael
  • Foley, Christopher
  • Gispert, Juan D.
  • Hill, Derek
  • Irizarry, Michael C.
  • Lammertsma, Adriaan A.
  • Molinuevo, José Luis
  • Ritchie, Craig
  • Scheltens, Philip
  • Schmidt, Mark E.
  • Visser, Pieter Jelle
  • Waldman, Adam
  • Wardlaw, Joanna
  • Haller, Sven
  • Barkhof, Frederik
  • SpringerLink (Online service)

Other Objects (12)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

The “rights” of precision drug development for Alzheimer’s disease

The “rights” of precision drug development for Alzheimer’s disease

Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review

Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

The plasma peptides of Alzheimer’s disease

The plasma peptides of Alzheimer’s disease

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease

Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory

Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory

Related objects